NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

Search:
	Advanced Search \| Site Map

The lines listed below are eligible for use in NIH funded research.

For guidance regarding applications proposing to use hESC see: NIH Guide Notices NOT-OD-10-020 and NOT-OD-10-029.

Eligible Lines:
Sorted by:
Date/Time:

147 (in 41 Submissions)
NIH Registration Number
02/09/2012 at 01:05 PM

Cell Line	NIH Registration Number (Use for NIH Applications *)	Provider	Submitting Organization	Approval Date
CHB-1 (see details)	0001 On Hold **	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-2 (see details)	0002 On Hold **	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-3 (see details)	0003 On Hold **	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-4 (see details)	0004	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-5 (see details)	0005	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-6 (see details)	0006	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-8 (see details)	0007	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-9 (see details)	0008	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-10 (see details)	0009	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-11 (see details)	0010	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
CHB-12 (see details)	0011	George Q. Daley, M.D., Ph.D.	Children's Hospital Corporation	12/02/2009
Rockefeller University Embryonic Stem Cell Line 1 (RUES1) (see details)	0012	The Rockefeller University, Ali Brivanlou	The Rockefeller University	12/02/2009
Rockefeller University Embryonic Stem Cell Line 2 (RUES2) (see details)	0013	The Rockefeller University, Ali Brivanlou	The Rockefeller University	12/02/2009
HUES 1 (see details)	0014	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 2 (see details)	0015	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 3 (see details)	0016	HUES Cell Facility	Harvard University	12/14/2009
HUES 4 (see details)	0017	HUES Cell Facility	Harvard University	12/14/2009
HUES 5 (see details)	0018	HUES Cell Facility	Harvard University	12/14/2009
HUES 6 (see details)	0019	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 7 (see details)	0020	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 8 (see details)	0021	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 9 (see details)	0022	Massachusetts Human Stem Cell Bank	Harvard University	12/14/2009
HUES 10 (see details)	0023	HUES Cell Facility	Harvard University	12/14/2009
HUES 11 (see details)	0024	HUES Cell Facility	Harvard University	12/14/2009
HUES 12 (see details)	0025	HUES Cell Facility	Harvard University	12/14/2009
HUES 13 (see details)	0026	HUES Cell Facility	Harvard University	12/14/2009
HUES 14 (see details)	0027	HUES Cell Facility	Harvard University	12/14/2009
HUES 15 (see details)	0028	HUES Cell Facility	Harvard University	12/14/2009
HUES 16 (see details)	0029	HUES Cell Facility	Harvard University	12/14/2009
HUES 17 (see details)	0030	HUES Cell Facility	Harvard University	12/14/2009
HUES 18 (see details)	0031	HUES Cell Facility	Harvard University	12/14/2009
HUES 19 (see details)	0032	HUES Cell Facility	Harvard University	12/14/2009
HUES 20 (see details)	0033	HUES Cell Facility	Harvard University	12/14/2009
HUES 21 (see details)	0034	HUES Cell Facility	Harvard University	12/14/2009
HUES 22 (see details)	0035	HUES Cell Facility	Harvard University	12/14/2009
HUES 23 (see details)	0036	HUES Cell Facility	Harvard University	12/14/2009
HUES 24 (see details)	0037	HUES Cell Facility	Harvard University	12/14/2009
HUES 26 (see details)	0038	HUES Cell Facility	Harvard University	12/14/2009
HUES 27 (see details)	0039	HUES Cell Facility	Harvard University	12/14/2009
HUES 28 (see details)	0040	HUES Cell Facility	Harvard University	12/14/2009
CyT49 (see details)	0041		ViaCyte, Inc.	01/19/2010
Rockefeller University Embryonic Stem Cell Line 3 (RUES3) (see details)	0042	The Rockefeller University, Ali Brivanlou	The Rockefeller University	01/19/2010
WA01 (H1) (see details)	0043	WiCell Research Institute	WiCell Research Institute	01/29/2010
UCSF4 (see details)	0044	Susan Fisher	University of California San Francisco	03/12/2010
NYUES1 (see details)	0045	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES2 (see details)	0046	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES3 (see details)	0047	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES4 (see details)	0048	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES5 (see details)	0049	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES6 (see details)	0050	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
NYUES7 (see details)	0051	Christoph Hansis, MD, PhD	New York University School of Medicine	03/29/2010
MFS5 (see details)	0052	Eric Chiao	Stanford University	04/27/2010
HUES 48 (see details)	0053	HUES Cell Facility	Harvard University	04/27/2010
HUES 49 (see details)	0054	HUES Cell Facility	Harvard University	04/27/2010
HUES 53 (see details)	0055	HUES Cell Facility	Harvard University	04/27/2010
HUES 65 (see details)	0056	HUES Cell Facility	Harvard University	04/27/2010
HUES 66 (see details)	0057	HUES Cell Facility	Harvard University	04/27/2010
UCLA 1 (see details)	0058		University of California, Los Angeles	04/27/2010
UCLA 2 (see details)	0059		University of California, Los Angeles	04/27/2010
UCLA 3 (see details)	0060		University of California, Los Angeles	04/27/2010
WA07 (H7) (see details)	0061	WiCell Research Institute	WiCell Research Institute	04/27/2010
WA09 (H9) (see details)	0062	WiCell Research Institute	WiCell Research Institute	04/27/2010
WA13 (H13) (see details)	0063	WiCell Research Institute	WiCell Research Institute	04/27/2010
WA14 (H14) (see details)	0064	WiCell Research Institute	WiCell Research Institute	04/27/2010
HUES 62 (see details)	0065	HUES Cell Facility	Harvard University	06/03/2010
HUES 63 (see details)	0066	HUES Cell Facility	Harvard University	06/03/2010
HUES 64 (see details)	0067	HUES Cell Facility	Harvard University	06/03/2010
CT1 (see details)	0068	University of Connecticut Stem Cell Core	UNIVERSITY OF CONNECTICUT SCH OF MED/DNT	06/21/2010
CT2 (see details)	0069	University of Connecticut Stem Cell Core	UNIVERSITY OF CONNECTICUT SCH OF MED/DNT	06/21/2010
CT3 (see details)	0070	University of Connecticut Stem Cell Core	UNIVERSITY OF CONNECTICUT SCH OF MED/DNT	06/21/2010
CT4 (see details)	0071	University of Connecticut Stem Cell Core	UNIVERSITY OF CONNECTICUT SCH OF MED/DNT	06/21/2010
MA135 (see details)	0072	Advanced Cell Technology, Inc.	Advanced Cell Technology, Inc.	06/21/2010
Endeavour-2 (see details)	0073	Kuldip Sidhu	Stem Cell Laboratory, Faculty of medicine, University of New South Wales	06/21/2010
WIBR1 (see details)	0074	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	06/21/2010
WIBR2 (see details)	0075	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	06/21/2010
HUES 45 (see details)	0076	HUES Cell Facility	Harvard University	09/28/2010
Shef 3 (see details)	0077	Centre for Stem Cell Biology	University of Sheffield	11/17/2010
Shef 6 (see details)	0078	Centre for Stem Cell Biology	University of Sheffield	11/17/2010
WIBR3 (see details)	0079	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	11/17/2010
WIBR4 (see details)	0080	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	11/17/2010
WIBR5 (see details)	0081	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	11/17/2010
WIBR6 (see details)	0082	Whitehead Institute for Biomedical Research/Maya Mitalipova	Whitehead Institute for Biomedical Research	11/17/2010
BJNhem19 (see details)	0083	Jawaharlal Nehru Centre for Advanced Scientific Research	Jawaharlal Nehru Centre for Advanced Scientific Research	12/17/2010
BJNhem20 (see details)	0084	Jawaharlal Nehru Centre for Advanced Scientific Research	Jawaharlal Nehru Centre for Advanced Scientific Research	12/17/2010
SA001 (see details)	0085	Cellartis AB	Cellartis AB	12/17/2010
SA002 (see details)	0086	Cellartis AB	Cellartis AB	12/17/2010
UCLA 4 (see details)	0087		University of California Los Angeles	02/03/2011
UCLA 5 (see details)	0088		University of California Los Angeles	02/03/2011
UCLA 6 (see details)	0089		University of California Los Angeles	02/03/2011
HUES PGD 13 (see details)	0090	HUES Cell Facility	Harvard University	03/15/2011
HUES PGD 3 (see details)	0091	HUES Cell Facility	Harvard University	03/15/2011
ESI-014 (see details)	0092	BioTime, Inc.	BioTime, Inc.	06/02/2011
ESI-017 (see details)	0093	BioTime, Inc.	BioTime, Inc.	06/02/2011
HUES PGD 11 (see details)	0094	HUES Cell Facility	Harvard University	06/07/2011
HUES PGD 12 (see details)	0095	HUES Cell Facility	Harvard University	06/07/2011
WA15 (see details)	0096	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA16 (see details)	0097	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA17 (see details)	0098	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA18 (see details)	0099	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA19 (see details)	0100	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA20 (see details)	0101	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA21 (see details)	0102	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA22 (see details)	0103	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA23 (see details)	0104	WiCell Research Institute	WiCell Research Institute	06/09/2011
WA24 (see details)	0105	WiCell Research Institute	WiCell Research Institute	06/09/2011
CSES2 (see details)	0106	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES4 (see details)	0107	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES7 (see details)	0108	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES8 (see details)	0109	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES11 (see details)	0110	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES12 (see details)	0111	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES13 (see details)	0112	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES14 (see details)	0113	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES15 (see details)	0114	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES17 (see details)	0115	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES19 (see details)	0116	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES20 (see details)	0117	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES21 (see details)	0118	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES22 (see details)	0119	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES23 (see details)	0120	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES24 (see details)	0121	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
CSES25 (see details)	0122	Juan Carlos Biancotti	Cedars-Sinai Medical Center	06/10/2011
HAD-C 100 (see details)	0123	Benjamin E. Reubinoff	Hadassah Hebrew University Medical Center	06/16/2011
HAD-C 102 (see details)	0124	Benjamin E. Reubinoff	Hadassah Hebrew University Medical Center	06/16/2011
HAD-C 106 (see details)	0125	Benjamin E. Reubinoff	Hadassah Hebrew University Medical Center	06/16/2011
RNJ19 (see details)	0126	Reprogenetics, LLC	Reprogenetics, LLC	06/16/2011
RNJ20 (see details)	0127	Reprogenetics, LLC	Reprogenetics, LLC	06/16/2011
RNJ18 (see details)	0128	Reprogenetics, LLC	Reprogenetics, LLC	06/16/2011
ESI-035 (see details)	0129	BioTime, Inc.	BioTime, Inc.	08/18/2011
ESI-049 (see details)	0130	BioTime, Inc.	BioTime, Inc.	08/18/2011
ESI-051 (see details)	0131	BioTime, Inc.	BioTime, Inc.	08/18/2011
ESI-053 (see details)	0132	BioTime, Inc.	BioTime, Inc.	08/18/2011
CSES5 (see details)	0133	Juan Carlos Biancotti	Cedars-Sinai Medical Center	09/27/2011
CSES6 (see details)	0134	Juan Carlos Biancotti	Cedars-Sinai Medical Center	09/27/2011
CSES18 (see details)	0135	Juan Carlos Biancotti	Cedars-Sinai Medical Center	09/27/2011
HUES PGD 14 (see details)	0136	HUES Cell Facility	Harvard University	10/11/2011
CA1 (see details)	0137	Andras Nagy	Mt Sinai Hosp-Samuel Lunenfeld Research Institute	12/12/2011
CA2 (see details)	0138	Andras Nagy	Mt Sinai Hosp-Samuel Lunenfeld Research Institute	12/12/2011
MEL-1 (see details)	0139	StemCore, Stem Cells Ltd	University of Queensland	12/22/2011
MEL-2 (see details)	0140	StemCore, Stem Cells Ltd	University of Queensland	12/22/2011
MEL-3 (see details)	0141	StemCore, Stem Cells Ltd	University of Queensland	12/22/2011
MEL-4 (see details)	0142	StemCore, Stem Cells Ltd	University of Queensland	12/22/2011
UCLA 7 (see details)	0143		University of California, Los Angeles	01/12/2012
UCLA 8 (see details)	0144		University of California, Los Angeles	01/12/2012
UCLA 9 (see details)	0145		University of California, Los Angeles	01/12/2012
UCLA 10 (see details)	0146		University of California, Los Angeles	01/12/2012
UM4-6 (see details)	0147	The University of Michigan	The University of Michigan	02/02/2012

Total Eligible Lines = 147

* NIH Registration Number:

The NIH registration number should be used on all NIH competing applications and annual progress reports to identify the stem cell line proposed for use. Identify the specific line(s) from the Registry using the NIH Registration Number (e.g., 0001), in the specified location in the application:

For grant applications using the SF424(R&R) electronic application packages, section 4 of the PHS398 Cover Page Supplement component provides fields in which to identify approved cell lines.
For grant applications using the SF424(R&R) Individual Fellowship electronic application packages, section C of the PHS Fellowship Supplemental Form component provides fields in which to identify approved cell lines.
For grant applications using the PHS 398 paper application form, the Human Embryonic Stem Cells section on page 3 provides a location in which to identify approved cell lines.

** On Hold - NIH has received public comment on a proposed change to the definition of “human embryonic stem cells” in the NIH Guidelines for Human Stem Cell Research. While NIH is considering those public comments on the proposed change, this hESC line is currently on hold and should not be used in NIH-funded research. If grantees are currently using any of these lines they may contact the NIH Institute or Center that is funding their project for further information.

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

hESC Line Listings:

NIH Form 2890:

Stem Cell Information: